Inhibitory impact of the anticancer drug doxorubicin on anaerobic microbial community

Aquat Toxicol. 2023 Nov:264:106706. doi: 10.1016/j.aquatox.2023.106706. Epub 2023 Sep 26.

Abstract

The inhibitory effect of the anticancer drug doxorubicin (DOX) on biogas production was evaluated in short-term and long-term exposure assays. The short-term assays reached the DOX IC50 value on 648 ± 50 µg·L-1. In addition, it was found that inhibition caused by the exposure of 10×103 µg·L-1 was reversible after removing DOX from the feeding synthetic medium. Furthermore, DOX can be rapidly sorbed by the biomass (despite the low Kow), which might contribute to the inhibitory effect. The results of long-term exposure assays, when the DOX volumetric loading rate was increased from 100 µgDOX·L-1·day-1 to 200 µgDOX·L-1·day-1, showed that biogas production and COD removal decreased rapidly. However, the methanogenic Archaeas could recover from this exposure, corroborating the results on short-term exposure assays. In conclusion, DOX can play a key role in inhibiting biological wastewater treatment processes if its concentration in hospital wastewater treatment plants increases abruptly.

Keywords: Acetoclastic methanogenesis; Anaerobic digestion; Anthracyclines; Antineoplastic drugs.

MeSH terms

  • Anaerobiosis
  • Antineoplastic Agents*
  • Biofuels
  • Bioreactors
  • Doxorubicin
  • Microbiota*
  • Waste Disposal, Fluid / methods
  • Water Pollutants, Chemical* / toxicity

Substances

  • Biofuels
  • Water Pollutants, Chemical
  • Doxorubicin
  • Antineoplastic Agents